
Ozempic patient blinded by NAION sues Novo Nordisk
Novo Nordisk has seen its first lawsuit over the proposed link between Ozempic and the rare eye disorder NAION.
Newsletters and Deep Dive digital magazine
Novo Nordisk has seen its first lawsuit over the proposed link between Ozempic and the rare eye disorder NAION.
A five-year genomics study that aims to transform the care of children with cancer and improve treatment success has launched in Ireland.
As a psychiatric provider working with people from all walks of life, I’ve seen how serious mental health conditions, particularly bipolar I disorder (BD-I), can present differently dependi
Women are being overlooked in the UK's HIV response and can face barriers to accessing prevention, testing and care, says a new campaign.
Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat APDS, an ultra-rare immunodeficiency disorder.
Editor's Picks
Newsletters and Deep Dive
digital magazine